Weekly Watch List

ALXN (7/24/11, +84.76%)
AAPL (4/29/12, -2.96%)
GNC (7/01/12, -2.53%)
ROST (7/22/12, +0.18%)
MNST (10/16/11, +44.47%)
TJX (3/25/12, +15.71%)
DG (4/8/12, +7.98%)
TFM (6/17/12, +9.95%)
ULTA (4/8/12, -8.06%)
MA (9/24/11, +29.59%)
VAL (7/01/12, -3.60%)
VRSK (7/15/12, +0.41%)

Additions:
None

Subtractions:
DLTR (7/08/12, -4.29%)

Last week, the major U.S. indexes moved higher. The Dow and the NYSE composite each surged 2.0%, the S&P 500 vaulted 1.7%, and the NASDAQ added 1.1%. The IBD outlook slid to “market in correction” on Wednesday, but then quickly rebounded to “confirmed uptrend” after Thursday’s gains on volume. Normally, a follow through day can’t occur until at least the fourth day of a new rally attempt. However, in this case, IBD calculated the rally attempt from the July 12th low, so the follow through day came on day ten. In any case, the uptrend was reconfirmed by Friday’s encouraging market action. Positive fiscal pronouncements out of Europe were primarily responsible for last week’s uptick in U.S. markets. If, and it’s still a big if, although it’s sounding more likely and could happen sooner rather than later, the Europeans take concrete, credible action to put their economic union in order, the U.S. markets will soar. You do not want to miss a rally like that, don’t get caught on the sidelines.

This week three watch list stocks are at or near proper buy points. ROST, trading at $67.26, is still within 5% of a $64.89 buy point, off of a 5th stage flat base, and has also found support at its 10 week line as it continues to meander sideways. TJX, trading at $44.70, is still barely within 5% of a $42.91 buy point off of a 2nd stage flat base. VRSK, trading at $50.86, is still within 5% of a $49.76 buy point, off of a 2nd stage flat base, and has also found support at its 10 week line.

/as usual, your mileage may vary, always do your own homework

Advertisements

Weekly Watch List

AAPL (4/29/12, +0.22%)
ALXN (7/24/11, +68.45%)
GNC (7/01/12, -3.95%)
ROST (7/22/12, +0.00%)
DG (4/8/12, +10.84%)
TJX (3/25/12, +14.70%)
DLTR (7/08/12, -5.36%)
MNST (10/16/11, +37.71%)
MA (9/24/11, +25.55%)
TFM (6/17/12, +0.25%)
VAL (7/01/12, -2.57%)
ULTA (4/8/12, -7.90%)
VRSK (7/15/12, -2.17%)

Additions:
VRSK (7/15/12, +0.00%)

Subtractions:
ROST (7/22/12, +0.00%)

Last week, the major U.S. indexes tread water. The Nasdaq added 0.6%, S&P 500 and the Dow each gained 0.4%, and the NYSE composite finished unchanged. The IBD outlook briefly changed to “confirm uptrend” on Thursday, but then immediately retreated back to “uptrend under pressure” after Friday’s session. Bad news from Europe is back in the driver’s seat, exercise appropriate caution. If I had to guess, I’d say we’re headed for another correction before another uptrend.

It’s obviously not the best time to make new purchases, but if you must, this week three watch list stocks are at or near proper buy points. ALXN, trading at $99.35, is still within 5% of a $95.11 buy point off of a 4th stage flat base. ROST, trading at $67.41, is still within 5% of a $64.89 buy point off of a 5th stage flat base TJX, trading at $44.31, is still within 5% of a $42.91 buy point off of a 2nd stage flat base.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

GNC (7/01/12, +0.13%)
ALXN (7/24/11, +65.06%)
AAPL (4/29/12, +0.33%)
MNST (10/16/11, +56.27%)
DLTR (7/08/12, -2.80%)
DG (4/8/12, +15.48%)
TJX (3/25/12, +15.95%)
TFM (6/17/12, +7.15%)
ULTA (4/8/12, -2.47%)
VAL (7/01/12, -0.65%)
HIBB (7/08/12, -0.32%)
MA (9/24/11, +27.47%)
VRSK (7/15/12, +0.00%)

Additions:
VRSK (7/15/12, +0.00%)

Subtractions:
None

Last week, the major U.S. indexes ended narrowly mixed. The S&P 500 inched up 0.2%, the Dow and NYSE composite finished flat, and the Nasdaq faded 1%. Tuesday’s across the board distribution day downgraded the IBD outlook to “uptrend under pressure”. It’s probably a good idea to hold off making any more new purchases for the time being, keep a close eye on your portfolio, and be prepared to cut losses quick if the market makes a break for the downside.

That said, if you insist on living dangerously, this week four watch list stocks are at or near proper buy points. ALXN, trading at $97.35, has dropped back to within 5% of a $95.11 buy point off of a 4th stage flat base. DLTR, trading at $52.77, after finding support at its 10 week line, is in buy range up to $59.66. TJX, trading at $44.79, is still barely within 5% of a $42.91 buy point after breaking out of a 2nd stage flat base. VRSK, trading at $50.65, broke past the $49.76 buy point of a 2nd stage flat base although, so far, volume has been lacking.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

GNC (7/01/12, +7.50%)
ALXN (7/24/11, +71.67%)
AAPL (4/29/12, +0.48%)
MNST (10/16/11, +55.64%)
DLTR (7/08/12, +0.00%)
DG (4/8/12, +15.61%)
ULTA (4/8/12, -1.45%)
TFM (6/17/12, +7.44%)
TJX (3/25/12, +15.01%)
MA (9/24/11, +31.04%)
VAL (7/01/12, +1.81%)
HIBB (7/08/12, +0.00%)

Additions:
DLTR (7/08/12, +0.00%)
HIBB (7/08/12, +0.00%)

Subtractions:
VRSK (6/10/12, +4.41%)

Last week, the major U.S. indexes ended mostly lower. The Nasdaq inched up 0.1%, the S&P 500 dipped 0.5%, the NYSE composite slipped 0.6%, and the Dow lost 0.8%. Despite Friday’s unnerving distribution day for the Nasdaq, in the wake of the pathetic June employment situation report, the IBD outlook remains at “confirmed uptrend”. Earnings season starts after the close Monday and the overall mood going in seems to be pessimistic. That said, ignore the “sentiment” and focus on what the markets actually do. An uptrend is an uptrend, take advantage of it while it lasts by prudently acquiring quality stocks as they break out of proper bases.

This week, four watch list stocks are at or near proper buy points. GNC, trading at $42.14, broke out of a 3rd stage cup base and is just above a $42.05 buy point. DLTR, trading at $54.29, found support at its 10 week line and is in buy range up to $59.66. TJX, trading at $44.43, is still within 5% of a $42.91 buy point after breaking out of a 2nd stage flat base. VAL, trading at $53.44, broke out of a 2nd stage cup base and sits just above a $53.06 buy point.

/as usual, your mileage may vary, always do your own homework

Weekly Watch List

ALXN (7/24/11, +62.68%)
GNC (7/01/12, +0.00%)
MNST (10/16/11, +53.47%)
AAPL (4/29/12, -3.20%)
ULTA (4/8/12, -4.44%)
DG (4/8/12, +15.27%)
TJX (3/25/12, +11.20%)
TFM (6/17/12, +3.66%)
VAL (7/01/12, +0.00%)
MA (9/24/11, +28.24%)
VRSK (6/10/12, +3.57%)

Additions:
GNC (7/01/12, +0.00%)
VAL (7/01/12, +0.00%)

Subtractions:
DLTR (6/3/12, +7.42%)

Last week, the major U.S. indexes moved higher. The NYSE composite gained 2.4%, the Dow moved up 1.9%, and the S&P 500 and the Nasdaq both added 1.5%. Monday’s downdraft pushed the markets into correction, but Friday’s monster upside move constituted a follow through day and moved the IBD outlook back to “confirmed uptrend”. It’s once again okay to make new purchases, but proceed with caution. As noted previously, uptrends in June and July haven’t historically performed particularly well.

This week, three watch list stocks are at or near a proper buy point. ALXN, trading at $99.30, is still within 5% of a $95.11 buy point, off of a 4th stage flat base. TJX, trading at $42.93, is just above a $42.91 buy point after breaking out of a 2nd stage flat base. VAL, trading at $52.49, has formed a 2nd stage cup base with a $53.06 buy point.

/as usual, your mileage may vary, always do your own homework